Mitochondrial dysfunction plays an important role in the etiology of neurodegenerative diseases. However, the progressive nature of neuronal loss in genetic models of mitochondrial dysfunction suggests the presence of compensatory mechanisms promoting neuronal survival under these conditions. Here, we identified the energy metabolism kinase LKB1 as a key regulator of the compensatory mechanisms activated in neurons, following mitochondrial dysfunction. To accomplish this, we have created an in vivo neurodegenerative model based on the deletion of the mitochondrial protein apoptosis-inducing factor (AIF) in postmitotic neurons. Loss of mitochondrial function caused by AIF deletion induced several adaptive mechanisms, including increased glycolysis and mitochondrial biogenesis. Importantly, the activation of these adaptive mechanisms was abrogated by the deletion of one allele of LKB1, resulting in impaired neuronal survival. Because loss of mitochondrial function is a central mechanism implicated in neurodegenerative diseases, modulation of LKB1-dependent pathways may represent an important strategy to preserve neuronal survival and function.
INTRODUCTION
Neurodegenerative diseases are characterized by a progressive loss of neurons that often affects specific neuronal populations. In recent years, mitochondrial dysfunction has emerged as a key factor contributing to this neuronal cell death in diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis [reviewed in (1 -4) ]. For example, loss of function of complex I of the electron transport chain (ETC) is an important feature of PD, whereas amyloid-b disrupts mitochondrial function, contributing to neuronal loss in AD (2, 5) .
To better understand the role of mitochondrial dysfunction in neurodegenerative diseases, several animal models of mitochondria loss of function have been generated. These include ablation of complex I (Ndufs4) and complex IV (Cox10) subunits (6, 7) , as well as loss of the mitochondrial transcription factor A (8) , all of which cause severe defects in oxidative phosphorylation (OXPHOS). Another example is apoptosisinducing factor (AIF), an evolutionary conserved mitochondrial protein that plays an essential role in the maintenance of mitochondrial structure and function and the downregulation of which causes neurodegeneration in mice (9) and a severe mitochondrial encephalomyopathy when mutated in humans (10) . Of note, while most animal models of loss of mitochondrial function show robust primary mitochondrial defects, the rate of neuronal loss is generally more progressive and limited to specific neuronal populations. Although this selective vulnerability of neurons has been proposed to be linked to differences in neuronal metabolism [reviewed in (4) ], the underlying causes remain poorly understood. In fact, while the activation of several cell death pathways has been characterized as a consequence of mitochondrial dysfunction, the nature and regulation of adaptive pathways allowing certain neuronal populations to survive under these circumstances remain an important question.
The serine/threonine kinase LKB1 is a master regulator of energy metabolism, restricting cell growth under energy † Present address: Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Trois-Rivières, G9A 5H7, Canada. * To whom correspondence should be addressed. Email: rslack@uottawa.ca # The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com Human Molecular Genetics, 2013, Vol. 22, No. 5 952-962 doi:10.1093/hmg/dds500 Advance Access published on November 27, 2012 stress conditions through the regulation 14 kinases that act on processes such as cell polarity, cell growth and metabolism (11, 12) . Among these, the best characterized LKB1 substrate is the AMP-dependent protein kinase AMPK, a kinase that regulates autophagy and prevents cell growth by inhibiting mammalian target of rapamycin (mTOR) (11, 12) . Given the key role of LKB1 in cellular adaptation to energy stress, it is an attractive candidate for the regulation of metabolically driven adaptive processes. Indeed, recent evidence suggests that LKB1 plays an important role in adapting skeletal muscle metabolic function in response to exercise (13, 14) . However, the role of LKB1 in the adult brain under basal conditions or following mitochondrial dysfunction remains an important question, as neurons differ significantly from muscle in their metabolic needs [reviewed in (15, 16) ].
We used the conditional deletion of AIF as a neurodegenerative model to study the role of LKB1 in the adaptive response of neurons to mitochondrial dysfunction. Although AIF deletion in postmitotic neurons resulted in mitochondrial fragmentation and loss of OXPHOS function, as previously observed in other tissues (17) (18) (19) (20) , no neuronal loss was observed in the cortex of 90 days old AIF KO (AKO) mice. This neuronal survival was dependent on the activation of several LKB1-dependent adaptive mechanisms, including increased glucose metabolism and mitochondrial biogenesis. Consequently, loss of one allele of LKB1 significantly increased cell death that was observed in the cortex of AKO animals. Altogether, these results demonstrate that LKB1 plays a critical role in neuronal adaptation to mitochondrial dysfunction. Because loss of mitochondrial function is an important aspect of neurodegenerative diseases, manipulation of LKB1-dependent pathways could provide new tools to promote neuronal survival in this context.
RESULTS

AIF deletion in postmitotic neurons disrupts mitochondrial function
The mitochondrial inner membrane protein AIF is essential for the maintenance of mitochondrial function and morphology and its loss causes mitochondrial fragmentation and decreased levels of ETC proteins (17) (18) (19) (20) . As loss of AIF affects both functional and structural aspects of mitochondrial function, we used AIF deletion in postmitotic neurons to address the neuronal response to mitochondrial dysfunction. AIF-floxed mice (18) were crossed with mice expressing Cre under the control of the CamkIIa promoter, resulting in recombination of the floxed AIF allele (null allele) in the cortex, the hippocampus and the striatum (AKO mice) (Fig. 1A) (21) . AIF deletion in the cortex was confirmed by western blot (Fig. 1B) , and neuron-specific loss of mitochondrial AIF immunostaining was confirmed by immunohistochemistry in the cortex (Fig. 1C) , striatum and hippocampus (not shown). Loss of AIF resulted in mitochondrial fragmentation that was accompanied by mitochondrial swelling, as evidenced by the double labeling of mitochondria with the mitochondrial outer membrane protein TOM20 and the matrix protein mtHSP70 (Fig. 1E, quantified in D) . This loss of mitochondrial structure was correlated with decreased levels of NDUFA9 (complex I), Core2 (complex III) and COX IV (complex IV), but not SDHA (complex II) (Fig. 1B, quantified in F) . Altogether, these results indicate that AKO recapitulates the mitochondrial defects previously reported upon AIF deletion in other tissues (17) (18) (19) (20) .
To address the consequences of mitochondrial dysfunction caused by AIF deletion on the survival of different neuronal populations, we first examined the general brain morphology in 90-day-old AKO by cresyl violet staining and visualization of cortical processes by MAP2 staining (Fig. 2A) . Consistent with the greater sensitivity of striatal neurons to mitochondrial dysfunction (22) , a small but significant neuronal loss (15%) was observed in AKO striatum (Fig. 2B ) when compared with their littermate controls. In contrast, there were neither gross morphological changes nor significant neuronal loss in the cortex or the hippocampus of AKO animals ( Fig. 2A, C  and D) , two other structures where Cre is expressed (21) (data not shown). AKO cortical thickness was, however, reduced by 15% (Fig. 2E ). Given that AKO animals had the same number of cortical neurons as their wild-type (WT) littermates, we explored the possibility that the reduced cortical thickness was the result of decreased cell size. Neuronal cell body volume was indeed significantly reduced in AKO cortical layers II/III, and a similar trend was observed in layer V neurons (Fig. 2F) , suggesting that the reduced cortical thickness is the consequence of decreased neuronal cell body volume.
As the absence of cell loss in the cortex could be the consequence of a delayed appearance of mitochondrial dysfunction, we evaluated cortical expression of AIF and complex I subunit NDUFA9 at different ages. AIF loss was evident as early as 30 days after birth, whereas loss of NDUFA9 was clearly apparent in 60 days old animals (Fig. 3A) . However, NDUFA9 levels were also decreased in some 30-day-old AKO by western blot (Fig. 3B , levels for four different AKO are plotted) and partially decreased in affected neurons by immunohistochemistry (Fig. 3C) . Altogether, these data suggest that AKO mitochondria are dysfunctional by 60 days of age at the latest and that AKO cortical neurons can, thus, survive at least a month with dysfunctional mitochondria. Of note, loss of mitochondrial complexes, including Core2, was most evident in layer V neurons (Oct6 + ) ( Fig. 4A, D ; quantified in B) that normally express the highest levels of several mitochondrial markers in their cell body (Fig. 4E, quantified in B) . Interestingly, these neurons are also more sensitive to the loss of the transcriptional co-activator PGC1a (23, 24) , an important regulator of mitochondrial biogenesis.
Activation of adaptive mechanisms in AKO cortical neurons
Recent evidence suggests a role of proteins involved in the regulation of metabolism in promoting neuronal survival under metabolic stress, although their physiological regulation in this context is not well understood. For example, PGC1a levels are decreased in several neurodegenerative diseases, and its reintroduction in neurons from disease models is protective (25) . As layer V neurons are the most affected in both AKO and PGC1a KO animals, we quantified PGC1a levels following AIF deletion. More precisely, to discriminate Human Molecular Genetics, 2013, Vol. 22, No. 5 953 potential layer-specific responses, PGC1a levels were analyzed by immunohistochemistry and not western blot. Loss of AIF resulted in the upregulation of PGC1a specifically in layer V neurons (Oct6 + cells; Fig. 5A , quantified in B), suggesting a link between the increased sensitivity of these neurons to the loss of mitochondrial markers and their requirement for mitochondrial biogenesis. A second example of a metabolic enzyme promoting neuronal survival following mitochondrial dysfunction is HKII, the enzyme regulating the first, rate limiting, step of glycolysis (26) . Interestingly, HKII levels were also increased in AKO cortical neurons (Fig. 5A , quantified in C).
Several metabolic pathways are regulated upon loss of ATP production in a fashion that depends on the activation of (B) Expression levels of various components of the ETC in the cortices of 90 days old WT and AKO animals. The following antibodies were used: NDUFA9 (complex I), SDHA (complex II), Core2 (complex III), Cox IV (complex IV) and ATP5A (ATP synthase). mtHSP70 was used as a mitochondrial loading control. (C) Neuronspecific loss of AIF in AKO mice. AIF expression was analyzed in the cortex of AKO animals by staining with an AIF-specific antibody (green) and an antibody against the neuronal marker NeuN (middle panels; red) or the mitochondrial marker mtHSP70 (lower panels; red), along with the nuclear stain DAPI (blue). Scale bar 10 mm. Representative images are shown. (D and E) Mitochondrial fragmentation in AKO neurons. Mitochondria in the cortex of AKO animals were visualized by co-staining with the outer membrane TOM20 (green) and the matrix protein mtHSP70 (red). Confocal images were taken using a 63× objective (E) and quantified in (D). Scale bar 10 mm. Representative images are shown in (E). (F) Protein levels from the western blots in (A) were quantified using Image J. The measurements from three animals per genotype were normalized to actin levels and expressed as fold change over WT + SD.
AMPK. In this way, AMPK reestablishes cellular energy balance by promoting ATP synthesis, while shutting down energy-consuming processes such as mTOR-dependent protein translation (11, 12) . Interestingly, loss of AIF also induced AMPK activation, as determined by its phosphorylation on residue S172 (Fig. 4D ). This correlated with a reduction in mTOR activity, as determined by decreased phosphorylation of the mTOR substrate 4eBP1 (Fig. 5D) . Altogether, our results suggest that loss of AIF triggers the activation of several compensatory mechanisms promoting the survival of cortical neurons.
LKB1 regulates the adaptive mechanisms induced by mitochondrial loss of function
LKB1 is an evolutionary conserved kinase that regulates energy metabolism through the control of key cellular processes such as cell polarity, cell growth, mitochondrial biogenesis and glucose metabolism (Fig. 6I ). This occurs in ways that are both dependent and independent of AMPK, its best characterized substrate (11, 12, 27) . Of note, PGC1a and HKII, activated as a consequence of AIF deletion, are both regulated in an LKB1-dependent manner in skeletal muscle (13, 14) . However, as metabolic control is significantly different in neurons and muscle (15, 16) , whether LKB1 regulates compensatory mechanisms in a similar fashion in cortical neurons remains unknown. Therefore, we determined the role of LKB1 in the activation of these compensatory mechanisms by conditionally deleting LKB1 (28) in AKO animals (using CamKIIa Cre). Strikingly, loss of only one allele of LKB1 was sufficient to decrease both LKB1 levels and AMPK phosphorylation in the cortex of 10 days old animals (Fig. 6A) , suggesting an important role for LKB1 in this context. Given that complete deletion of LKB1 leads to loss of axonal growth in neural precursors (29, 30) and that AMPK phosphorylation was notably decreased in LKB1 heterozygotes, we used a LKB1 heterozygote for all subsequent experiments. These animals were similar to their littermate controls in all aspects tested, including axonal tracts (Fig. 6B) , clearly distinguishing them from the embryonic phenotype previously reported (29, 30) .
To address the role of LKB1 in the regulation of the adaptive mechanisms activated by the loss of AIF, we first quantified PGC1a expression in response to LKB1 deletion. The decrease in LKB1 expression in the LKB1 heterozygote did not affect basal PGC1a expression (Fig. 6C) . However, the increase in PGC1a expression previously noted in AKO Oct6 + neurons was abolished following the deletion of one allele of LKB1 (Fig. 6C) .
To further substantiate PGC1a activation, we quantified the expression of SOD1, a cytosolic PGC1a target gene (31) . A cytosolic target was chosen because levels of mitochondrial proteins might not reflect their transcription, due to degradation following mitochondrial dysfunction. Consistent with PGC1a activation, SOD1 levels were increased in AKO mice, and this was abrogated by the deletion of one allele of LKB1 (Fig. 6D) . Altogether, these results indicate a role for LKB1 in the activation of PGC1a triggered by mitochondrial dysfunction in the absence of AIF.
Given the importance of glycolysis for ATP production in the absence of functional mitochondria, we next addressed changes in glucose metabolism, following AIF deletion. GLUT3, a glucose transporter expressed in the CNS specifically in neurons, was previously shown to be upregulated following energy stress (32) . GLUT3 levels were indeed increased in AKO cortical neurons (Fig. 6F) , similar to the increase observed for the glycolitic enzyme HKII (Fig. 5A and  C) . Strikingly, although the deletion of one allele of LKB1 did not significantly alter the basal expression of these proteins, it abrogated the increase caused by AIF deletion (Fig. 6E and F) . This suggests that LKB1 plays an important role in the regulation of glycolysis, following mitochondrial dysfunction in cortical neurons.
Finally, given that cell size is usually controlled by mTOR, a master regulator of protein translation that is inhibited in AKO animals (Fig. 5D) , we addressed the contribution of LKB1 in the regulation of cell size. Loss of one allele of LKB1 prevented the reduction in cell size caused by AIF deletion in layer II/III neurons (Fig. 6G) , consistent with a role for LKB1. However, LKB1 deletion did not prevent the decrease in cell volume observed in layer V neurons (Fig. 6H) . Given that our results suggest an important role for LKB1 in the metabolic adaptation to mitochondrial dysfunction and that layer V and VI neurons are more sensitive to energy stress, the inability of LKB1 deletion to rescue layer V neurons' cell body volume could result from the induction of cell death in these neurons. Therefore, we determined the effect of the loss of one allele of LKB1, and the abrogation of the compensatory mechanisms it regulates, on the survival of cortical neurons.
LKB1 regulates cortical neuronal survival, following mitochondrial dysfunction
Although AKO mice had the same number of cortical neurons than their WT littermates, loss of one allele of LKB1 in conjunction with AIF deletion (AKOL) caused a 10% reduction in the number of cortical neurons (Fig. 7A) , suggesting that deletion of one allele of LKB1 sensitizes neurons to cell death following deletion of AIF. To specifically address the apoptotic cell loss, we analyzed caspase-3 activation in the cortex of AIF KO mice that were either WT or heterozygous for LKB1. Surprisingly, given the absence of neuronal loss in the AKO, some active caspase-3(AC3)-positive cells were observed in AKO layer V neurons starting at 90 days (Fig. 7B) . However, as no significant changes in AC3 were observed before 90 days, this time point represents the onset of neuronal loss in AKO neurons. This interpretation is supported by the cell death data in the AKOL animals. Although deletion of one allele of LKB1 did not cause an increase in AC3-positive cells in the presence of AIF, apoptotic cell death occurred significantly earlier (60 days) in AKOL and increased at a greater rate than their AKO littermates (Fig. 7B) . This is consistent with the observed neuronal loss in AKOL brains (Fig. 7A) . As with AKO animals, most AC3-positive cells in the double mutant were also positive for the layer V marker Oct6 (Fig. 7C) , further indicating that the defects are neuron specific. The data are also in agreement with the greater sensitivity of layer V neurons to cell death under energy stress (23, 24) and the decreased cell volume of AKOL layer V neurons when compared with layer II/III neurons (Fig. 6G) . Indeed, deletion of one allele of LKB1 in AKO animals was associated with a significant decrease in the number of layer V (Oct6 + ) neurons when compared with AKO, for which we did not observe a significant loss at 90 days (Fig. 7D) . Altogether, these results indicate that the activation of LKB1-regulated pathways is required for survival of AIF null neurons. Therefore, our results suggest that LKB1 plays an important role in neuronal adaptation to mitochondrial dysfunction and could, thus, be a key protein in the regulation of neuronal survival in the context of neurodegenerative diseases. 
DISCUSSION
Loss of mitochondrial function is a major characteristic of many neurodegenerative diseases. For example, while mutations in mitochondrial proteins such as ETC components or proteins involved in mitochondrial dynamics often cause neurodegeneration, sporadic cases of AD and PD are also linked to altered mitochondrial function (1 -3) . Similarly, human mutations in the mitochondrial protein AIF cause a severe mitochondrial encephalomyopathy (10) . We have now used CamKIIa Cre to delete AIF and cause mitochondrial dysfunction in postmitotic neurons, thereby creating a novel model of neurodegeneration. However, as with many models of mitochondrial loss of function in neurons (6 -9), neuronal loss following AIF deletion was progressive and limited to a specific neuronal population (striatum).
This neuronal survival is the consequence of the activity of energy metabolism kinase LKB1. Specifically, we demonstrated here that LKB1 plays a critical role in the regulation of neuronal survival, following the loss of mitochondrial function by activating several compensatory mechanisms that promote adaptation to energy stress. Thus, AIF deletion triggered the LKB1-dependent upregulation of mitochondrial biogenesis and glycolysis, compensatory mechanisms that were abrogated by the deletion of one allele of LKB1. By preventing the activation of these compensatory mechanisms, loss of LKB1 caused the death of these neurons, highlighting the critical role of this protein in metabolic stress adaptation and neuronal survival.
Previous work has indicated that LKB1 is a master regulator of energy metabolism under energy stress conditions (11, 12) . Indeed, a role for LKB1 in maintaining muscle metabolic function during exercise has been previously suggested (13, 14) . However, as the regulation of ATP production differs greatly in neurons and muscle (15, 16) , the role of LKB1 in the adult brain remains unknown. Indeed, the main function of LKB1 that has been described in neurons is during development, through the regulation of axon formation (29, 30) . Nevertheless, in contrast to the dramatic in vivo loss of axons when LKB1 is deleted in neuronal progenitors (29,30), we did not observe obvious axonal defects (Fig. 6B) . This suggests that LKB1 controls distinct cellular functions in precursors and differentiated cells, with a greater role of metabolic regulation of survival in postmitotic neurons. This would be consistent with the more important role of autophagy previously observed in postmitotic neurons, when compared with neural precursors (33). Sections from 90 days old animals were stained for PGC1a (red), the layer V marker Oct6 (green) and the nuclear stain DAPI (blue). Alternatively, sections were stained for HKII (red) and DAPI (blue). Sections were imaged with a 63× objective using a confocal microscope. Scale bar 10 mm. Representative images are shown. Data were quantified in (B) for PGC1a and (C) for HKII from at least three animals per genotype + SD.
* P , 0.05. (D) Expression levels of phospho-AMPK and phospho-4eBP1 in the cortices of 90 days old WT and AKO animals.
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AIF deletion leads to loss of ETC components and decreased ATP production (17) (18) (19) . It is, therefore, noteworthy that the compensatory mechanisms activated in an LKB1-dependent manner following AIF deletion play key roles in promoting ATP production. For example, GLUT3 and HKII both promote increased glycolysis, through glucose uptake and activation of a rate-limiting step of glycolysis, respectively. In addition, it has previously been reported that the activation of PGC1a can partially alleviate the mitochondrial dysfunction caused by the loss of ETC components (34) . Together, these mechanisms likely promote the survival of AKO neurons by maintaining ATP production, despite the loss of mitochondrial function characterizing these cells. Interestingly, mitochondrial HKII has recently been shown to regulate BAX recruitment to mitochondria, thereby inhibiting cytochrome c release and apoptosis (26) . It is, therefore, possible that, in addition to regulating ATP production, these pathways promote cell survival by regulating more directly the apoptotic machinery.
Given the importance of mitochondrial dysfunction in neurodegenerative diseases, the role of LKB1 in neuronal adaptation to mitochondrial dysfunction could be highly relevant to these diseases. It is, therefore, noteworthy that several lines of evidence point to a causal relationship between mitochondrial dysfunction and other important features of neurodegenerative diseases such as increased reactive oxygen species (ROS) and accumulation of misfolded proteins (2, 3) . Although this relationship is complex and not yet fully understood, it raises the possibility that the LKB1 pathway also promotes neuronal survival, following accumulation of ROS or misfolded proteins, a possibility that clearly warrants further investigation.
MATERIALS AND METHODS
Animals
All experiments were approved by the University of Ottawa's Animal Care Ethics Committee adhering to the Guidelines of the Canadian Council on Animal Care. To generate forebrainspecific AIF KO mice, the previously described floxed AIF mice on a FVBN background (18) were crossed with CamKIIa-Cre mice (C57Bl/6) (21). AIF mice were also crossed with LKB1 conditional mice [from Dr Ronald DePinho (28) ]. To minimize phenotypic variations that could result from the mixed background, the mice were kept on this FVBN/C57Bl/6 background for at least six generations before analyzing the mice, and littermates were used as controls for all experiments. Animals were genotyped according to standard protocols with previously published primers for AIF, LKB1 and Cre.
Tissue processing and immunohistochemistry
Mice were euthanized with a lethal injection of sodium pentobarbitol. For immunohistochemistry, mice were perfused with 1× PBS followed by fresh cold 4% paraformaldehyde (PFA). Brains were then removed, postfixed overnight in 4% PFA, cryoprotected in 20% sucrose in 1× PBS and frozen. Sections were collected as 14 mm coronal cryosections on Superfrost Plusw slides (Fisher Scientific). For western blot analysis, brains were removed, cortices dissected and flash frozen in liquid nitrogen.
Brain sections were analyzed by immunohistochemistry using AlexaFluor and Cy3 secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.). Images were taken using a Zeiss 510 meta confocal microscope. Where noted, composite images were created by juxtaposing multiple higher resolution images in Adobe Photoshop. All quantification was done blind on at least three sections per brain. Layer V neurons were identified as Oct6 + neurons, whereas the most superficial neurons were considered layer II/III. To measure the neuronal cell body volume, sections were aligned using the anterior commissure and stained with an antibody against the neuronal marker NeuN, which stains both the nuclei and cytosol of neurons. Z stacks were then taken using a 63× objective on a Zeiss 510 meta confocal microscope, and the surface area was calculated for each neuron in every z section using Image J. Because the sections were thin (14 mm), the volume was estimated by measuring the four bigger area of each cell multiplied by the z stack thickness. To quantify in an unbiased way the expression of proteins basally expressed in neurons, but for which the expression was altered in AKO neurons, the intensity of the immunofluorescent signal in the cell body was compared with that of an area outside cell bodies. A neuron with a 2-fold difference was considered positive.
Antibodies and immunoblots
The following antibodies were used: mouse anti-LDH H and mouse anti-actin (Sigma-Aldrich); goat anti HKII, goat anti-Oct6, rabbit anti-MAP2, mouse anti-LKB1, rabbit anti-GLUT3, rabbit anti-PGC1a, goat anti-AIF, rabbit anti-SOD1 and rabbit anti-TOM20 (Santa Cruz Biotechnologies); mouse anti-Core2, mouse anti-NDUFA9, mouse anti-SDHA (complex II p70) and mouse anti-COX IV (Invitrogen); rabbit anti-phospho-AMPK, rabbit anti-AMPK, rabbit anti-phospho4eBP1, rabbit anti-4eBP1 and rabbit anti-active caspase-3 (Cell Signaling Technologies); mouse anti-NeuN (Chemicon); rabbit anti-NeuN (EnCor Biotechnologies Inc.); rat anti-L1 (Millipore); mouse anti-ATP5A (Mitosciences); and mouse anti-mtHSP70 (ABR Bioreagents). Tissue was resuspended in 2% SDS, 62.5 mM Tris pH 6.8, 10% glycerol and boiled for 10 min. Alternatively, for phospho antibodies, tissue was lyzed in 10 mM Tris -HCl, pH 7.9, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 supplemented with protease inhibitors mixture (Sigma-Aldrich) and phosphatase inhibitors. For immunoblot analysis, proteins were subjected to SDS PAGE, transferred to nitrocellulose membranes and blotted with specific antibodies. Blots were incubated with HRP-conjugated secondary antibodies and visualized by enhanced chemiluminescence (Amersham Biosciences). Western blot quantification was performed using the Image J software and normalizing to actin levels.
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